Scheduling conflicts delay the FDA’s Orthopaedic & Rehabilitation Devices Panel, during which the agency was planning to discuss a possible reclassification of shortwave diathermy devices.

The FDA’s Orthopaedic & Rehabilitation Devices Panel postponed today’s meeting over scheduling conflicts that meant key players couldn’t attend.

The meeting was convened to discuss a possible reclassification of shortwave diathermy devices, which are used to therapeutically heat tissue with an electric current with applications in joint inflammation treatments and physiotherapy.